Korro Bio KRRO
NASDAQ KRRO
$9.64 -0.07 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Cash & Current Investments (2018 - 2026)

Updated

Korro Bio's Cash & Current Investments was $115.04 million in Q2 2026, up 19.4% from $96.36 million a year earlier and up 0.9% from the prior quarter.

Analysis

Korro Bio (KRRO) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Korro Bio came in at $75.16 million, down 40.4% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $126.1 million in FY2024 (-24.1%), $166.15 million in FY2023 (+200.7%), $55.25 million in FY2022 (-57.7%) and $130.71 million in FY2021 (-40.7%).
  • The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q4 2024.
  • Compared with a year earlier, Cash & Current Investments was higher in two of the last eight quarters, with growth averaging 11.7%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q2 2024 (growth of 238.7%); the worst was Q2 2023 (a decline of 58.1%).
  • Per Business Quant data, KRRO's Cash & Current Investments in the three quarters before Q2 2026 was $113.97 million (Q1 2026), $75.16 million (Q4 2025) and $92.48 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Korro Bio 141.76 Mn -254.88 Mn - 115.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 115.04 Mn
Mar 31, 2026 113.97 Mn
Dec 31, 2025 75.16 Mn
Sep 30, 2025 92.48 Mn
Jun 30, 2025 96.36 Mn
Mar 31, 2025 114.95 Mn
Dec 31, 2024 126.10 Mn
Sep 30, 2024 137.00 Mn
Jun 30, 2024 157.43 Mn
Mar 31, 2024 138.80 Mn
Dec 31, 2023 166.15 Mn
Sep 30, 2023 41.72 Mn
Jun 30, 2023 46.48 Mn
Mar 31, 2023 66.65 Mn
Dec 31, 2022 55.25 Mn
Sep 30, 2022 99.35 Mn
Jun 30, 2022 111.02 Mn
Mar 31, 2022 117.36 Mn
Dec 31, 2021 130.71 Mn
Sep 30, 2021 148.07 Mn
API Access

Korro Bio Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KRRO&period=max&api_key=YOUR_API_KEY